{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:11:10Z","timestamp":1790745070560,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1296,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1084693"],"award-info":[{"award-number":["APP1084693"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1147657"],"award-info":[{"award-number":["APP1147657"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1111\/ajt.15197","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T12:54:46Z","timestamp":1543582486000},"page":"1452-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["The clinical and pathological significance of borderline T cell\u2013mediated rejection"],"prefix":"10.1016","volume":"19","author":[{"given":"Brian J.","family":"Nankivell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Taverniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chow H.","family":"P\u2019Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Shingde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.15197_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int."},{"issue":"3","key":"10.1111\/ajt.15197_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201805 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15197_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15197_bib4","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1111\/ajt.13784","article-title":"Banff borderline changes suspicious for acute T cell-mediated rejection: where do we stand?","volume":"16","author":"Becker","year":"2016","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15197_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.15197_bib6","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/TP.0000000000002327","article-title":"Impact of the current versus the previous diagnostic threshold on the outcome of patients with borderline changes suspicious for T-cell-mediated rejection diagnosed on indication biopsies","volume":"102","author":"McRae","year":"2018","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15197_bib7","doi-asserted-by":"crossref","unstructured":"Nankivell BJ, P\u2019Ng CH, Chapman JR. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection [published online ahead of print 2018]? Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.14888.","DOI":"10.1111\/ajt.14888"},{"issue":"7","key":"10.1111\/ajt.15197_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/00007890-199710150-00010","article-title":"Clinical significance of renal allograft biopsies with \u201cborderline changes\u201d, as defined in the Banff Schema","volume":"64","author":"Saad","year":"1997","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15197_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0272-6386(96)90471-0","article-title":"Significance of the Banff borderline biopsy","volume":"28","author":"Schweitzer","year":"1996","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"10.1111\/ajt.15197_bib10","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"issue":"6","key":"10.1111\/ajt.15197_bib11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1600-6143.2005.00830.x","article-title":"Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center","volume":"5","author":"Choi","year":"2005","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15197_bib12","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/ajt.14933","article-title":"Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation","volume":"18","author":"Seifert","year":"2018","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15197_bib13","first-page":"391","article-title":"Utility of serial protocol biopsies performed after 1 year in predicting long-term kidney allograft function according to histologic phenotype","volume":"16","author":"Zachariah","year":"2018","journal-title":"Exp Clin Transplant."},{"issue":"10","key":"10.1111\/ajt.15197_bib14","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/ndt\/14.10.2364","article-title":"An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome","volume":"14","author":"Bates","year":"1999","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1111\/ajt.15197_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-6143.2011.03784.x","article-title":"The nature of biopsies with \u201cborderline rejection\u201d and prospects for eliminating this category","volume":"12","author":"de Freitas","year":"2012","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15197_bib16","doi-asserted-by":"crossref","first-page":"292305","DOI":"10.1155\/2014\/292305","article-title":"The utility of serial allograft biopsies during delayed graft function in renal transplantation under current immunosuppressive regimens","volume":"2014","author":"Hatoum","year":"2014","journal-title":"ISRN Nephrol."},{"issue":"1","key":"10.1111\/ajt.15197_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000225783.86950.c2","article-title":"Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants","volume":"82","author":"Kee","year":"2006","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15197_bib18","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1681\/ASN.V1081806","article-title":"The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies","volume":"10","author":"Meehan","year":"1999","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"10.1111\/ajt.15197_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-0012.2005.00303.x","article-title":"Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction","volume":"19","author":"Miyagi","year":"2005","journal-title":"Clin Transplant."},{"issue":"2","key":"10.1111\/ajt.15197_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.TP.0000128167.60172.CC","article-title":"Natural history, risk factors, and impact of subclinical rejection in kidney transplantation","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation."},{"issue":"suppl 1","key":"10.1111\/ajt.15197_bib21","first-page":"24","article-title":"Borderline changes on dysfunctional renal allograft biopsies: clinical relevance in a living related renal transplant setting","volume":"15","author":"Mubarak","year":"2017","journal-title":"Exp Clin Transplant."},{"issue":"6","key":"10.1111\/ajt.15197_bib22","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/S0041-1345(99)00355-3","article-title":"Borderline changes in kidney transplantation: evolution of treated cases versus nontreated","volume":"31","author":"Palomar","year":"1999","journal-title":"Transplant Proc."},{"key":"10.1111\/ajt.15197_bib23","doi-asserted-by":"crossref","first-page":"583981","DOI":"10.1155\/2011\/583981","article-title":"Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal","volume":"2011","author":"Heilman","year":"2011","journal-title":"J Transplant."},{"issue":"1","key":"10.1111\/ajt.15197_bib24","first-page":"25","article-title":"The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies","volume":"26","author":"Masin-Spasovska","year":"2005","journal-title":"Prilozi."},{"issue":"10","key":"10.1111\/ajt.15197_bib25","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1600-6143.2011.03695.x","article-title":"Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation","volume":"11","author":"Thierry","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15197_bib26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15197_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e3182777efb","article-title":"Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal","volume":"95","author":"Gaber","year":"2013","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15197_bib28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.TP.0000118905.98469.91","article-title":"Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation","volume":"77","author":"Roberts","year":"2004","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15197_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1997.38","article-title":"Early protocol renal allograft biopsies and graft outcome","volume":"51","author":"Seron","year":"1997","journal-title":"Kidney Int."},{"issue":"9","key":"10.1111\/ajt.15197_bib30","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15197_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.15197_bib32","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial effects of treatment of early subclinical rejection: a randomized study","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15197_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117753616","article-title":"Practice patterns in the treatment and monitoring of acute T cell-mediated kidney graft rejection in Canada","volume":"5","author":"Leblanc","year":"2018","journal-title":"Can J Kidney Health Dis."},{"issue":"4","key":"10.1111\/ajt.15197_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/ajt.13572","article-title":"Using molecular phenotyping to guide improvements in the histologic diagnosis of T cell-mediated rejection","volume":"16","author":"Reeve","year":"2016","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15197_bib35","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.transproceed.2008.09.031","article-title":"Multifocal renal allograft biopsy: impact on therapeutic decisions","volume":"40","author":"Piovesan","year":"2008","journal-title":"Transplant Proc."},{"issue":"11","key":"10.1111\/ajt.15197_bib36","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/00007890-199512000-00007","article-title":"Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection","volume":"60","author":"Sorof","year":"1995","journal-title":"Transplantation."},{"issue":"suppl 21","key":"10.1111\/ajt.15197_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-0012.2009.01105.x","article-title":"Borderline rejection after renal transplantation\u2013to treat or not to treat","volume":"23","author":"Beimler","year":"2009","journal-title":"Clin Transplant."},{"issue":"4","key":"10.1111\/ajt.15197_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1399-0012.2005.00377.x","article-title":"Reproducibility of the Banff classification in subclinical kidney transplant rejection","volume":"19","author":"Veronese","year":"2005","journal-title":"Clin Transplant."},{"issue":"10","key":"10.1111\/ajt.15197_bib39","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","article-title":"Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome","volume":"11","author":"Bestard","year":"2011","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15197","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15197","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15197","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:22:44Z","timestamp":1761628964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522090797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1600613522090797"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15197","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical and pathological significance of borderline T cell\u2013mediated rejection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}